Benzene

Benzene

SCHEMBL2235833

NS(N)(=O)=O.c1ccccc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 14/20 0.67
CA2 P00918 14/20 0.67
CA9 Q16790 8/20 0.67
CA5A P35218 5/20 0.67
CA7 P43166 4/20 0.67
CA4 P22748 4/20 0.67
CA6 P23280 4/20 0.67
CA5B Q9Y2D0 3/20 0.67
CA12 O43570 3/20 0.47
CA14 Q9ULX7 2/20 0.47
CA3 P07451 1/20 0.47
PLA2G7 Q13093 1/20 0.47
CA13 Q8N1Q1 1/20 0.47
TSHR P16473 2/20 0.42
NT5E P21589 1/20 0.42
NPC1 O15118 1/20 0.36
MTOR P42345 1/20 0.36
RAB9A P51151 1/20 0.36
HTR6 P50406 1/20 0.35
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL6258462 1.00 CA1 (0.67) CA1CA2CA9CA5ACA7
Benzene SCHEMBL10457003 1.00 CA1 (0.67) CA1CA2CA9CA5ACA7
Sulfamide SCHEMBL5880 0.82
Benzene SCHEMBL2344334 0.80 CA1 (0.73) CA1CA2CA9CA5ACA7
Benzene SCHEMBL17784484 0.80 CA1 (0.42) CA1CA2CA9CA5ACA7
Benzene SCHEMBL6661878 0.80 CA1 (0.73) CA1CA2CA9CA5ACA7
Biphenyl SCHEMBL187355 0.78 CA2 (0.67) CA1CA2CA9CA5ACA7
Pyridine SCHEMBL11570751 0.78 NAPRT (0.60) CA1CA2CA9CA5ACA7
Benzene SCHEMBL28967058 0.77 CA2 (0.40) CA1CA2CA9CA5ACA7
Sulfamide SCHEMBL3409127 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103893178-B Benzene-sulfamide compound is in the application prepared in anti-HIV-1 virus drugs Guangzhou Zhongheng Electronic Technology Co.,Ltd. (CN) 2016-06-01 CN claimed
CN-103893178-A Application of benzene-sulfamide compounds in preparing anti-HIV-1(human immunodeficiency virus-1) drug UNIV SUN YAT SEN 2014-07-02 CN claimed
EP-0275918-B1 PROCESS FOR THE PREPARATION OF IMIDIZED ACRYLIC POLYMERS ATOCHEM INDUSTRIALE s.r.l. (IT) 1992-03-25 EP claimed
US-4968755-A Imidized acrylic polymers and process for their preparation VEDRIL S.P.A. (IT) 1990-11-06 US claimed
EP-0275918-A2 Process for the preparation of imidized acrylic polymers ATOCHEM INDUSTRIALE s.r.l. (IT) 1988-07-27 EP claimed
EP-0073463-B1 INSERTION COMPOUNDS, INTERCALATION COMPOUNDS AND SOLID SOLUTIONS OF COLOURED METALLIC ORGANIC DERIVATIVES BAYER AG (DE) 1985-10-23 EP claimed
JP-8295078-A None JP disclosed
EP-4389711-A1 PROCESS OF DECONTAMINATION OF A RECOVERED CELLULOSIC WASTE STREAM FOR ITS SUBSEQUENT TRANSFORMATION INTO FERMENTABLE SUGARS INSTITUTO TECNOLÓGICO DEL EMBALAJE, TRANSPORTE Y LOGÍSTICA (ITENE) (ES) 2024-06-26 EP disclosed
CN-113897603-A Corrosion-resistant palladium electroless plating solution and application thereof 信丰正天伟电子科技有限公司 2022-01-07 CN disclosed
CN-110128396-B Xanthone bridged sulfonamide derivative and preparation method and application thereof 中山大学 2021-05-18 CN disclosed
US-10080742-B2 Isoxazole derivatives as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2018-09-25 US disclosed
CN-108276376-A Novel two allyl benzene derivatives of one kind and preparation method thereof, a kind of pharmaceutical composition 北京理工大学 2018-07-13 CN disclosed
US-9927697-B2 Mask blank, method of manufacturing mask blank and method of manufacturing transfer mask HOYA CORPORATION (JP) 2018-03-27 US disclosed
EP-0275918-A2 Process for the preparation of imidized acrylic polymers ATOCHEM INDUSTRIALE s.r.l. (IT) 1988-07-27 EP disclosed
US-4729936-A WIDE TEMPERATURE RANGE, PYRAZOLE COMPOUNDS FUJI PHOTO FILM CO., LTD. (JP) 1988-03-08 US disclosed
EP-0244177-A2 Method for processing light-sensitive silver halide color photographic material KONICA CORPORATION (JP) 1987-11-04 EP disclosed
US-4695525-A HEAT DEVELOPMENT, PYRAZOLONE FUJI PHOTO FILM CO., LTD. (JP) 1987-09-22 US disclosed
US-4642247-A PROPELLING INK DROPLETS ON SUBSTRATE HAVING WATER-SORPTIVE UNDERLAYER, WATER RESISTANT COVER LAYER CANON KABUSHIKI KAISHA (JP) 1987-02-10 US disclosed
EP-0205079-A2 Acid disulfimide triphenodioxazine dyes BAYER AG (DE) 1986-12-17 EP disclosed
US-4001290-A LACQUERS, COATINGS, ADHESIVES, TELOMERS, FOAM PLASTICS BAYER AKTIENGESELLSCHAFT (DT) 1977-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10080742-B2 Isoxazole derivatives as FXR agonists and methods of use thereof FXR1, SLC10A1, NR1H4 CA1 2185/4885CA2 2111/4885CA9 2927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.